Head To Head Top Stocks: Goldman Sachs Group, Inc. (The) (NYSE:GS), Laboratory Corporation of America Holdings (NYSE:LH)

Goldman Sachs Group, Inc. (The) (NYSE:GS)

Goldman Sachs Group, Inc. (The) (NYSE:GS) closed at $198.21 on the last trading session with an decrease of -0.66%, whereas, it previously closed at $199.53. The company has a market capitalization of $69.14 Billion. The company traded shares of 475764 on the trading day while its three month average volume stands at 3.62 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Goldman Sachs Group, Inc. (The) (NYSE:GS) produced diluted EPS of 18.85. The EPS estimate for next year as estimated by analysts is at 22.59 while EPS for next quarter is estimated at 4.34. Earnings per Share growth for this year is reported at -12.4, while the analysts estimated the EPS growth for next year at 22.59% and Earnings growth for next 5 years stands at 6.11% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 4.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Goldman Sachs Group, Inc. (The) (NYSE:GS) is at 10.59 while the forward p/e is at 8.83. The P/S or Price to Sales ratio of Goldman Sachs Group, Inc. (The) (NYSE:GS) stands at 1.26 and Price to Book or P/B for the most recent quarter stands at 0.88. The Price to Free Cash Flow ratio or P/FCF is reported at 4.98. The quick ratio and the current ratio of Goldman Sachs Group, Inc. (The) (NYSE:GS) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Goldman Sachs Group, Inc. (The) (NYSE:GS) stands at 0.8, 9.8 and 1.3 respectively

The trailing twelve month Revenue of Goldman Sachs Group, Inc. (The) (NYSE:GS) is reported at 54.72 Billion with income of 6.89 Billion. The outstanding shares of Goldman Sachs Group, Inc. (The) (NYSE:GS) are 358 Million. The institutional Ownership of the shares of 74.5 stands at 0.80%, this figure is increased 0.16 in the last six months. The insider ownership for the shares of Goldman Sachs Group, Inc. (The) (NYSE:GS) is ticked at 0.3%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Goldman Sachs Group, Inc. (The) (NYSE:GS) is the Mean Target Price estimated by the analysts which stands at 245.16. The 52 week high of Goldman Sachs Group, Inc. (The) (NYSE:GS) is placed at 250.46 and 52 week low is standing at 130.85.

Performance wise the shares of Goldman Sachs Group, Inc. (The) (NYSE:GS) fell down -1.72% for the week, it also rise 0.97% for the monthly performance, while for the quarter it went down 8.78%. The shares decrease -18.27% for the half year and plummeted for the Year-To-Date performance. The shares of Goldman Sachs Group, Inc. (The) (NYSE:GS) shrinked -9.36% for the yearly performance.

Laboratory Corporation of America Holdings (NYSE:LH)

Laboratory Corporation of America Holdings (NYSE:LH) closed at $191.08 on the last trading session with an decrease of -1.93%, whereas, it previously closed at $194.84. The company has a market capitalization of $18.94 Billion. The company traded shares of 87218 on the trading day while its three month average volume stands at 853.49 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Laboratory Corporation of America Holdings (NYSE:LH) produced diluted EPS of 3.25. The EPS estimate for next year as estimated by analysts is at 14.18 while EPS for next quarter is estimated at 1. Earnings per Share growth for this year is reported at -7.7, while the analysts estimated the EPS growth for next year at 14.18% and Earnings growth for next 5 years stands at 7.7% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 7.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Laboratory Corporation of America Holdings (NYSE:LH) is at 59.97 while the forward p/e is at 13.74. The P/S or Price to Sales ratio of Laboratory Corporation of America Holdings (NYSE:LH) stands at 1.63 and Price to Book or P/B for the most recent quarter stands at 2.7. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Laboratory Corporation of America Holdings (NYSE:LH) are reported at 1.1 and 1.2 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Laboratory Corporation of America Holdings (NYSE:LH) stands at 0, 0 and 7.5 respectively

The trailing twelve month Revenue of Laboratory Corporation of America Holdings (NYSE:LH) is reported at 11.59 Billion with income of 321 Million. The outstanding shares of Laboratory Corporation of America Holdings (NYSE:LH) are 97.2 Million. The institutional Ownership of the shares of 93.8 stands at 0.80%, this figure is decreased -0.58 in the last six months. The insider ownership for the shares of Laboratory Corporation of America Holdings (NYSE:LH) is ticked at 0.5%, the figure is plummeted -11.3% in the last six months.

Some other important financial aspects to be discussed here for Laboratory Corporation of America Holdings (NYSE:LH) is the Mean Target Price estimated by the analysts which stands at 217.36. The 52 week high of Laboratory Corporation of America Holdings (NYSE:LH) is placed at 206.74 and 52 week low is standing at 98.02.

Performance wise the shares of Laboratory Corporation of America Holdings (NYSE:LH) fell down -1.97% for the week, it also rise 17.3% for the monthly performance, while for the quarter it went down 18.48%. The shares increase 8.82% for the half year and flew up for the Year-To-Date performance. The shares of Laboratory Corporation of America Holdings (NYSE:LH) grew 16.31% for the yearly performance.